Navigation Links
Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause
Date:6/2/2011

EMERYVILLE, Calif., June 2, 2011 /PRNewswire/ -- Bionovo, Inc. (NASDAQ: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced it will be presenting data from the Phase 2 clinical trial of their lead drug candidate for postmenopausal symptoms, Menerba (also known as MF101), to the international community at the 13th Annual World Congress on Menopause in Rome, Italy on June 11, 2011.

The Phase 2 clinical trial was designed to evaluate the safety and efficacy of two doses of Menerba versus placebo. The trial was a randomized, double-blinded, placebo-controlled study that enrolled 217 healthy postmenopausal women reporting moderate to severe hot flashes. Further analysis of the data was performed to evaluate if the clinical efficacy of Menerba correlates with the willingness of postmenopausal women to use Menerba for the treatment of hot flashes. We found that 73% of women with >/= 50% reduction in hot flashes and 77% of women with >/= 60% reduction in hot flash frequency were willing to continue treatment after 12 weeks of therapy. In our responder analysis, women randomized to Menerba 10 grams/day were 2.3 and 2.4 fold more likely to have >/= 50% or >/= 60% reduction in all hot flashes at 12 weeks of treatment compared to placebo (OR 2.3, p=0.03 or OR 2.4, p=0.02) respectively.

"I am very encouraged by our findings, which show that postmenopausal women are willing to take a safe, non-hormonal agent, such as Menerba, if the frequency of hot flashes is reduced by 50-60%. We know that Menerba has a demonstrated level of efficacy similar to low dose estrogen preparations and is in the target range for approval by the FDA," said Mary Tagliaferri, M.D., Bionovo's President and Chief Medical Officer. "We are eager to initiate our Phase 3 clinical tria
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
2. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
3. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
4. Bionovos Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation
5. Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
6. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
7. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
8. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
9. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
10. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
11. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... BerGenBio AS ("BerGenBio" or the ... has appointed Hilde Furberg and Dr ... of Directors, effective immediately. Hilde Furberg ... and biotech and is currently Senior Vice President Rare ... role was Vice President and General Manager of Nordic ...
(Date:8/31/2015)...  DICOM Grid,  the #1 medical image exchange ... as a semifinalist for a Minnie award for ... are sponsored by Auntminnie.com, a comprehensive community website ... imaging industry.  Since 1999, the "Minnies" have provided ... contributions of their peers. Nominations are made by ...
(Date:8/31/2015)... 2015 Thousands of people will peacefully demonstrate ... opioid addiction epidemic at dozens of rallies across the ... the United States has experienced ... opioids and heroin, yet the President has never once ... letter to President Obama , rally organizers compared ...
Breaking Medicine Technology:BerGenBio Appoints Non-Executive Directors 2DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2Obama Administration's Neglect of Opioid Crisis Prompts Rallies in Many States 2
(Date:9/1/2015)... ... September 01, 2015 , ... Discovia, a leading ... today that it has hired Scott Sanderson, an experienced business development professional and ... will be responsible for establishing and managing new client relationships in the Southeast ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... Zecurion, a ... Mac , its groundbreaking new version of endpoint DLP developed specifically for Mac OS. ... in which more than 100 IT and information security professionals had participated. The beta ...
(Date:9/1/2015)... ... 01, 2015 , ... Two of Washington D.C.’s most respected chefs are using ... , Recently named “the next big thing” in the culinary world by Elle ... whole story behind food and reclaiming culinary traditions on the brink of extinction. According ...
(Date:9/1/2015)... ... 2015 , ... METTLER TOLEDO has announced an upcoming webinar ... , featuring Ed Szczesny (Quality Assurance, Rhodes Pharmaceuticals) as guest presenter. This webinar ... , Calibration, qualification, and the appropriate level of routine testing for laboratory instruments ...
(Date:9/1/2015)... OH (PRWEB) , ... September 01, 2015 , ... Mercy ... – has devoted the 10th of its monthly Mercy Health: Helping You Be Well ... affecting one in seven men. , In a concise video on Mercy Health’s ...
Breaking Medicine News(10 mins):Health News:Former NFL Standout Scott Sanderson Joins eDiscovery Leader Discovia 2Health News:Zecurion Announces Endpoint Security for Mac 2Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 2Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 3Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 4Health News:Live Webinar from Pharmaceutical Technology and METTLER TOLEDO on Calibration and Qualification of Laboratory Instruments 2Health News:New Mercy Health Video Explains Most-Common Cancer Found in Men 2
... , Helps PSI, ... , HARARE, Zimbabwe, Dec. 10 Emmy Award ... is in Zimbabwe celebrating organizations, donors and individuals who have ... the country. Over the past six years Zimbabwe has ...
... A never-approved drug developed to prevent the death of nerve ... keeping normal cells healthy and intact, an international team led ... journal Breast Cancer Research . Prof. Malka ... stroke drug a member of a family of phenanthridine ...
... , "...it is also true that security ... food, or clean water, or the medicine they need to survive ... International Human Rights Day -- At his Nobel Peace Prize acceptance speech ... health and access to medicines for all people as a prerequisite to ...
... , New report ... colorectal cancer could decline by 36 percent , Oak ... Gastrointestinal Endoscopy (ASGE) lauds the recent news of the decline in ... week, shows that from 1975 to 2000, incidence rates dropped 22 ...
... Non-profit faith-based community health center to add third North Philadelphia ... , PHILADELPHIA, Dec. 10 President Obama announced yesterday nearly ... to fund major construction and renovation projects at a total ... award to Esperanza Health Center in North Philadelphia. Esperanza, ...
... ... in CRM consulting, integration and deployment, has partnered with Adventace, a ... and results from their CRM application via the High Performance Sales ... methodology from Adventace. HPSE provides executives and sales managers an ...
Cached Medicine News:Health News:Emmy Award Winning Actress Debra Messing Visits Zimbabwe 2Health News:Emmy Award Winning Actress Debra Messing Visits Zimbabwe 3Health News:Finding the Achilles' heel of cancer 2Health News:GAA Calls on President Obama to Make Good on His Nobel Peace Prize Speech 2Health News:ASGE Lauds Drop in Colorectal Cancer Deaths 2Health News:ASGE Lauds Drop in Colorectal Cancer Deaths 3Health News:ASGE Lauds Drop in Colorectal Cancer Deaths 4Health News:Esperanza Health Center Receives $6.5 Million in Stimulus Funds 2Health News:Salesforce CRM Users Outperform Past Results by a Factor of at Least 50% 2Health News:Salesforce CRM Users Outperform Past Results by a Factor of at Least 50% 3
The CH 2000 Cardiac Diagnostic system is a fully featured stress testing system that can include Microvolt T-Wave Alternans (MTWA) testing capability as an add-on feature. , ,Interfaces with Tra...
... The Volk G-1 trabeculum provides the highest ... Perfect for viewing and treating the trabecular meshwork. ... of the anterior chamber angle while the central ... view the posterior pole for signs of glaucoma ...
... AFX (Air Fluid eXchange) Lens ... designed for use in an ... its use as a primary ... low profile and sutureless design ...
... The 45° Prism is ... pathologies and are recommended ... (PDR, BRVO etc.) and ... can be used for ...
Medicine Products: